Cleaning composition with improved dispersion and suspension properties

Abstract

This invention relates to a method for producing dispersions with improved dispersing properties. The compositions are particularly, but not exclusively, suitable for water-based applications such as personal care and the washing of textiles and dishes, especially as hand dishwashing liquids. This invention also relates to the dispersion obtained by the method and its use as a shampoo, textile detergent, or dishwashing liquid, particularly as a hand dishwashing liquid. In a further aspect, the invention relates to a method for treating a substrate using the dispersion.

Description

Field of invention This invention relates to a method for producing dispersions with improved dispersing properties. The compositions are particularly, but not exclusively, suitable for water-based applications such as personal care and the washing of textiles and dishes, especially as hand dishwashing liquids. This invention also relates to the dispersion obtained by the method and its use as a shampoo, textile detergent, or dishwashing liquid, particularly as a hand dishwashing liquid. In a further aspect, the invention relates to a method for treating a substrate using the dispersion. State of the art Active ingredients with various beneficial properties are frequently used in fluid formulations, particularly in personal care products or in cleaning formulations for dishes, preferably hand dishwashing liquids, or textiles. In these applications, it is often necessary to add structuring or thickening ingredients to these formulations to prevent migration of the active ingredients due to gravity. Current technology reveals mild washing compositions with good foaming properties, based on biosurfactants. These washing compositions can be used for personal care or for washing textiles, hard surfaces, or even as hand dishwashing detergents. The WO 2019 / 154970 A1 comprehensively describes glucolipids in detergent compositions and body care products. WO 2014 / 118095 A1 discloses a foaming washing composition comprising a synthetic anionic surfactant, a glycolipid surfactant, and optionally an encapsulated active ingredient. This washing composition is suitable for personal hygiene or for handwashing laundry or dishes, particularly when used in water with a high calcium ion content (“hard” water) or process water. Process water is utility water that does not meet the minimum requirements for drinking water but is used in technical, commercial, agricultural, or domestic applications. WO 2011 / 120776 A1 describes a mild, foaming, aqueous cleaning composition based on the combination of various surfactants with biosurfactants such as rhamnolipids or sophorolipids. WO 2014 / 173659 A1 describes suitable cleaning agents for laundry or dishes in which rhamnolipids are used to adjust viscosity. These cleaning agents are characterized by advantageous dispersion. The object of the invention was to provide a cleaning agent for laundry or dishes, in particular a hand dishwashing detergent, which comprises an encapsulated active ingredient (“benefit agent”) and has improved dispersion compared to the cleaning agents of the prior art, in particular compared to those according to WO 2014 / 173659 A1. Description of the invention Surprisingly, a method for producing a dispersion D has now been found that solves the aforementioned problems. It was also surprisingly discovered that the dispersions D obtained by this method are characterized by particularly good dispersion, meaning that the dispersion is especially stable. 1. Method for producing a dispersion D The present invention therefore relates to a method for producing a, preferably aqueous, dispersion D of active ingredient capsules W comprising at least one active ingredient B. The process comprises the following steps: a) providing a mixture M comprising a surfactant combination, preferably consisting of i. at least one glucolipid G, ii. at least one surfactant TS, b) adding the active ingredient capsules WK to M, thereby obtaining a dispersion D. Furthermore, it was found that the dispersions D obtained by the inventive method are suitable as advantageous liquid cleaning compositions and thus solve the problem of the invention. The dispersions D obtained by the inventive method are preferably applied to substrates and are suitable for cleaning substrates such as fabrics (textiles) or nonwovens, or hard surfaces, in particular dishes. The dispersions D obtained according to the invention are also advantageous because the glucolipid offers improved rheology-modifying properties for compositions with dispersed, and in particular suspended, active ingredients compared to other biosurfactants such as rhamnolipids. Active ingredients can be suspended in the dispersions D according to the invention without the need for additional suspension technologies (such as structuring agents). At the same time, due to the shear-thinning properties of the dispersions D according to the invention, it is possible to dose them precisely through smaller openings for accurate delivery / dosing. The dispersion D according to the invention is preferably used in handwashing detergents or hand dishwashing detergents, and even more preferably in hand dishwashing detergents. "Hand dishwashing agent" (also "hand dishwashing detergent") is any cleaning agent that can be used for rinsing or washing dishes. It can also be referred to as "hand dishwashing detergent". 1.1 Step a) In step a) of the process according to the invention, a mixture M comprising a surfactant combination is provided. The surfactant combination preferably comprises i. at least one glucolipid G and ii. at least one surfactant Ts. 1.1.1 Biosurfactants Glucolipids G, as well as rhamnolipids and sophorolipids, are biosurfactants and, like methods for their synthesis, are known to those skilled in the art from, for example, WO 2019 / 154970 A1, EP 0 499 434 A1 (glucolipids are referred to as "glucoselipids" in this document), DE 196 48 439 A1, DE 196 00 743 A1. EP 3 061 442 A2, WO 03 / 006146 A1, US 2008 / 0213194 A1, JP H01-304034 A1, CN 1337439 A describe methods for the production of glucolipids and rhamnolipids. WO 03 / 002700 A1 , US 4,305,961 A , US 7,556,654 B1 describe methods for the production of sophorolipids. Within the scope of the present invention, it was surprisingly found that glucolipids enable stable dispersions of active ingredient capsules in detergents, in particular hand dishwashing detergents, compared to the stabilizing effect that can be achieved with rhamnolipids or sophorolipids. 1.1.1.1 Glucolipid G Preferably, the glucolipid G used in the process according to the invention, which is comprised of the mixture M, and the glucolipid G comprised of the dispersion D according to the invention, have a structure selected from the following structural formulas (I), (XIV), wherein it is preferably a structure of structural formula (I), and more preferably the following structural formula (II): In the structural formulas (I) and (II) mGL = 3, 2, 1 or 0, preferably 1 or 0. The residues R1GLand and R2GL are each independently an organic residue with 2 to 24, preferably 5 to 20, more preferably 7 to 15, and more preferably 7, carbon atoms. Preferably, R1GL and R2GL are each independently selected from the group consisting of i. optionally substituted alkyl groups with 2 to 24, preferably 5 to 20, more preferably 7 to 15, more preferably 7, carbon atoms, wherein the substitution with at least one, in particular exactly one, hydroxy group is the preferred substitution; ii. optionally substituted alkenyl groups with 2 to 24, preferably 5 to 20, more preferably 7 to 15, more preferably 7, carbon atoms, wherein the substitution with at least one, in particular exactly one, hydroxy group is the preferred substitution. R1GL and R2GL are preferred, each independently selected from the group consisting of pentenyl, heptenyl, nonenyl, undecenyl, tridecenyl and -(CH2)o-CH3, where o = 1 to 23, preferably 4 to 12. R1GL and R2GL are most preferred, each being n-heptyl. Different glucolipids are abbreviated in cases where mGL = 0 using the following nomenclature: “GL-CX” means glucolipids of the general formulas (I) or (II) where mGL = 0 and where the residue is R1GL= -(CH2)o-CH3 with o = X-4. Different glucolipids are abbreviated in cases where mGL = 1, using the following nomenclature: “GL-CXCY” means glucolipids of the general formulas (I) or (II) where mGL = 1 and where one of the residues R1GL and R2GL = -(CH2)o-CH3 with o = X-4 and the other of the residues R1GL and R2GL = -(CH2)o-CH3 with o = Y-4. This nomenclature therefore does not distinguish between "CXCY" and "CYCX". If one of the indices X and / or Y is supplemented with “:Z”, this means that the respective residue R1GL or R2GL is an unbranched, unsubstituted hydrocarbon residue with X-3 or Y-3 carbon atoms and Z double bonds. The serpentine bond in structural formula (I) [and also in the structural formula (III) described below] means that the respective substituent is oriented axially or equatorially, preferably equatorially. Alkyl groups can be linear or branched. Alkenyl groups can be linear or branched and preferably have one to three double bonds. In cases where the compounds of structural formulas (I) or (II) have more than one residue R2GL, the residues R2GL can be the same or different from each other. Alternatively or additionally, compounds (so-called “di-glucolipids”) of the following general structural formula (XIV) can also be used as glucolipid G: The following applies in the structural formula (XIV): In the structural formula (XIV) mGL = 3, 2, 1 or 0, preferably 1 or 0. The residues R1GL and R2GL are identical or different and each is an organic residue with 2 to 24 carbon atoms, preferably 5 to 20, more preferably 7 to 15, and even more preferably 7 carbon atoms, wherein the residues R1GL and R2GL are preferably selected independently of each other from the group consisting of optionally substituted alkyl residues with 2 to 24, preferably 5 to 20, more preferably 7 to 15, and even more preferably 7 carbon atoms, wherein hydroxy-substituted alkyl residues are preferred substituted alkyl residues, optionally substituted alkenyl residues with 2 to 24, preferably 5 to 20, more preferably 7 to 15, and even more preferably 7 carbon atoms, wherein hydroxy-substituted alkenyl residues are preferred substituted alkenyl residues, wherein the residues R1GL and R2GL are preferably selected independently of each other. selected from each other are from the group consisting of pentenyl, heptenyl, nonenyl, undecenyl, tridecenyl and -(CH2)oCH3, where o = 1 to 23, preferably 4 to 12.R1GL and R2GL are both n-heptyl. One of the residues RG2, RG3, RG4 and RG6 is a residue of the general structural formula (T), and the three remaining residues RG2, RG3, RG4 and RG6 are each hydrogen. In the general structural formula (T) one of TG1, TG2, TG3, TG4 and TG6, preferably TG1, is a direct bond to the structure (XIV), while the other four of TG1, TG2, TG3, TG4 and TG6 are each hydroxy, wherein it is preferred that TG1 is a direct bond to the structure (XIV), while TG2, TG3, TG4 and TG6 are each hydroxy. The serpentine bond in structural formulas (XIV) and (T) means that the respective residue is in an axial or equatorial position, preferably an equatorial position, relative to the sugar ring. In embodiments in which compounds of structural formula (XIV) have more than one residue R2GL, these residues R2GL may be the same or different. The glucolipid G used in the process according to the invention, which is comprised of the mixture M, and the glucolipid G comprised of the dispersion D according to the invention, can also be present as a salt. In this embodiment, it is preferred that the glucolipid G is present as a salt in which the cation is selected from the group consisting of Li+, Na+, K+, Mg2+, Ca2+, Al3+, NH4+, and ammonium ions, which may be primary, secondary, or tertiary ammonium ions. Particularly preferred cations are selected from the group consisting of Na+, K+, NH4+, and the triethanolammonium cation. Preferred ammonium cations are selected from the group consisting of tetramethylammonium, tetraethylammonium, tetrapropylammonium, tetrabutylammonium, [(2-Hydroxyethyl)trimethylammonium] (= choline) as well as the cations of 2-aminoethanol (“MEA”), diethanolamine (“DEA”), 2,2',2"-nitrilotriethanol (“TEA”), 1-aminopropan-2-ols, ethylenediamines, diethylenetriamines, triethylenetetramines, tetraethylenepentamines, 1,4-diethylenediamines, piperazine, aminoethylpiperazine and aminoethylethanolamines. Mixtures of the aforementioned cations can also be used as cations of the glucolipid salts. 1.1.1.2 Rhamnolipids Rhamnolipids are in particular compounds of the following structural formula (III) and their salts, preferably compounds of the following structural formula (IV) and their salts: In the structural formulas (III) and (IV) mRL = 2, 1 or 0, preferably 1 or 0. In structural formulas (III) and (IV) nRL = 1 or 0. The residues R1RL and R2RL are each independently an organic residue with 2 to 24, preferably 5 or 13 carbon atoms. Preferably, R1RL and R2RL are each independently selected from the group consisting of i. optionally substituted alkyl groups with 2 to 24, preferably 5 to 13, carbon atoms, wherein substitution with at least one, in particular exactly one, hydroxy group is the preferred substitution; ii. optionally substituted alkenyl groups with 2 to 24, preferably 5 to 13, carbon atoms, wherein substitution with at least one, in particular exactly one, hydroxy group is the preferred substitution. Preferably R1RL and R2RL are each independently selected from the group consisting of pentenyl, heptenyl, nonenyl, undecenyl, tridecenyl and -(CH2)o-CH3, where o = 1 to 23, preferably 4 to 12. For nRL = 1, the glycosidic bond between the two rhamnose units is preferentially in the α-configuration. The optically active carbon atoms of the fatty acid residues are preferentially R-enantiomers (e.g., (R)-3-{(R)-3-[2-O-(α-L-rhamnopyranosyl)-α-L-rhamnopyranosyl]oxydecanoyl}-oxydecanoate). “Di-rhamnolipids” (“Di-RL”) are those compounds of structural formulas (III) and (IV) or their salts for which nRL = 1. “Mono-rhamnolipids” (“Mono-RL”) are those compounds of structural formulas (III) and (IV) or their salts for which nRL = 0. Different rhamnolipids are abbreviated using the following nomenclature: “diRL-CXCY” refers to di-rhamnolipids of structural formulas (III) and (IV), in which one of the residues R1RL and R2RL = -(CH2)o-CH3 with o = X-4 and the other of the residues R1RL and R2RL = -(CH2)o-CH3 with o = Y-4. “monoRL-CXCY” refers to mono-rhamnolipids of structural formulas (III) and (IV), in which one of the residues R1RL and R2RL = -(CH2)o-CH3 with o = X-4 and the other of the residues R1RL and R2RL = -(CH2)o-CH3 with o = Y-4. This nomenclature therefore does not distinguish between "CXCY" and "CYCX". For rhamnolipids with mRL=0, the terms “monoRL-CX” or “diRL-CX” are used accordingly. If one of the indices X and / or Y is supplemented with “:Z”, this means that the respective residue R1RL or R2RL is an unbranched, unsubstituted hydrocarbon residue with X-3 or Y-3 carbon atoms and Z double bonds. In cases where the compounds of structural formulas (III) or (IV) have more than one R2RL residue, the R2RL residues can be the same or different from each other. 1.1.1.3 Sophorolipids Sophorolipids are in particular compounds of the following structural formula (V), (VII) and their salts, preferably compounds of the following structural formula (VI), (VIII) and their salts: Compounds with structural formulas (V), (VI) represent the acid form, compounds with structural formulas (VII), (VIII) represent the lactone form. In the structural formulas (V), (VI), (IX) and (X), nSL = 1 or 0, preferably 1. In structural formulas (V), (VI), (VII) and (VIII) [and also for the residues R1SL, R2SL and R4SL in structural formulas (IX), (X), (XI) and (XII)]: R1SL = H or -CO-CH3, R2SL = H or -CO-CH3, R3SL = a divalent organic residue with 6 to 32 carbon atoms, preferably 12 to 20, more preferably 14 to 16, most preferably 15 carbon atoms. R3SL is preferably an optionally substituted divalent hydrocarbon residue with 6 to 32 carbon atoms, wherein substitution with at least one, in particular exactly one, hydroxy residue is the preferred substitution. R3SL is preferably selected from the group consisting of i. optionally substituted alkylene residues with 6 to 32, preferably 12 to 20, more preferably 14 to 16, most preferably 15 carbon atoms, wherein the substitution with at least one, in particular exactly one, hydroxy residue is the preferred substitution, and wherein the carbon chain in the alkylene residue is preferably unbranched; ii.optionally substituted alkenylene residues with 6 to 32, preferably 12 to 20, more preferably 14 to 16, most preferably 15 carbon atoms, wherein substitution with at least one, in particular exactly one, hydroxyl group is the preferred substitution, and wherein the carbon chain in the alkenylene residue is preferably unbranched, and wherein the alkenylene residue preferably has 1 to 3, more preferably one double bond. R3S is more preferably selected from the group consisting of i. unbranched or branched, preferably unbranched, alkylene residues with 6 to 32, preferably 12 to 20, more preferably 14 to 16, most preferably 15 carbon atoms; ii. unbranched or branched, preferably unbranched, alkylene residues with 6 to 32, preferably 12 to 20, more preferably 14 to 16, most preferably 15 carbon atoms, wherein in each case the alkylene residue has at least one OH group, preferably one OH group; iii.unbranched or branched, preferably unbranched, alkenylene residues with 6 to 32, preferably 12 to 20, more preferably 14 to 16, most preferably 15 carbon atoms, wherein the alkenylene residue in each case preferably has one to three, more preferably one double bond; iv. unbranched or branched, preferably unbranched, alkenylene residues with 6 to 32, preferably 12 to 20, more preferably 14 to 16, most preferably 15 carbon atoms, wherein the alkenylene residue in each case preferably has one to three, more preferably one double bond, wherein in each case the alkenylene residue has at least one OH group, more preferably one OH group, and wherein the alkenylene residue preferably has one to three, more preferably one double bond. R4SL = H, CH3 or a monovalent organic residue with 2 to 10 carbon atoms.R4SL is preferably selected from the group consisting of: • H, • CH3, • optionally substituted alkyl group with 2 to 10 carbon atoms, which is preferably unbranched, wherein the substitution with at least one, in particular exactly one, hydroxy group is the preferred substitution, • optionally substituted alkenyl group with 2 to 10 carbon atoms, which is preferably unbranched, wherein the substitution with at least one, in particular exactly one, hydroxy group is the preferred substitution, wherein it is preferred that the optionally substituted alkenyl group has one to three, preferably one, double or triple bond(s), preferably double bond(s).R4SL is more preferably selected from the group consisting of: • H, • CH3, • unbranched or branched, preferably unbranched, alkyl group with 2 to 10 carbon atoms, • unbranched or branched, preferably unbranched, alkyl group with 2 to 10 carbon atoms, which has at least one, preferably one, hydroxy group, • unbranched or branched, preferably unbranched, alkenyl group with 2 to 10 carbon atoms, wherein the alkenyl group has one to three, preferably one, double or triple bond(s), preferably double bond(s), • unbranched or branched, preferably unbranched, alkenyl group with 2 to 10 carbon atoms, wherein the alkenyl group has one to three, preferably one, double or triple bond(s), preferably double bond(s), and wherein the alkenyl group has at least one, preferably one, hydroxy group. R4SL is most preferably selected from the group consisting of: H, Methyl, Ethyl. Sophorolipids are preferably compounds of the following structural formula (IX), (XI) and their salts, preferably compounds of the following structural formula (X), (XII) and their salts: Compounds with structural formulas (IX), (X) represent the acid form, compounds with structural formulas (XI), (XII) represent the lactone form. nSL, R1SL, R2SL, R4SL have the meanings as described for the structural formulas (V), (VII), (VI), (VIII). Sophorolipids can be used as mixtures of the acid and lactone forms; for example, the ratio of the weight of sophorolipid used in lactone form to the weight of sophorolipid used in acid form can be in the range of 20:80 to 80:20, preferably in the range of 30:70 to 40:60. The ratio between the acid and lactone forms can be determined according to EP 1 411 111 B1, page 8, paragraph

[0053] . Sophorolipids can be obtained as described in EP 1 411 111 A1, paragraphs

[0021] ,

[0022] . Derivatives of sophorolipids, in particular those described in EP 4 317 448 A1 or EP 3 034 613 A1, can also be used as sophorolipids. 1.1.2 Salts The mixture M provided in step a) of the process according to the invention and the dispersion D obtained in the process according to the invention preferably comprise salts. These salts can have organic or inorganic cations, in particular cations selected from alkali metal cations or alkaline earth metal cations, preferably cations selected from the group consisting of Li+, Na+, K+, Cs+, Ca2+, Mg2+. The anions of these salts are in particular selected from the group consisting of halide ions, preferably Cl-, or ammonium ions, preferably amides, trialkylammonium ions, in particular triethylammonium ions. A preferred salt is sodium chloride (NaCl). In a preferred embodiment, the total content of all salts in the dispersion D obtained in the inventive process is in the range of 0.01 wt.% to 5 wt.%, preferably in the range of 0.5 wt.% to 2 wt.%, in each case based on the total weight of the dispersion D. It is preferred that the mass of all glucolipids G in the mixture M provided in step a), relative to the total weight of all glucolipids G and all surfactants Ts in the mixture M provided in step a), is in the range of 10 wt.% to 95 wt.%, in particular in the range of 25 wt.% to 75 wt.%. It is therefore also preferred that the mass of all glucolipids G in the dispersion D obtained in the process according to the invention, based on the total weight of all glucolipids G and all surfactants Ts in the dispersion D obtained in the process according to the invention, is in the range of 10 wt.% to 95 wt.%, in particular in the range of 25 wt.% to 75 wt.%. 1.1.3 Surfactant TS It goes without saying that surfactant TS is different from glucolipid G. In particular, surfactant TS is not a biosurfactant, and therefore not a glucolipid, rhamnolipid, sophorolipid, or a derivative thereof. The surfactant TS is in particular selected from the group consisting of anionic surfactants, non-ionic surfactants, cationic surfactants, amphoteric surfactants, preferably selected from the group consisting of anionic surfactants, non-ionic surfactants, and most preferably an anionic surfactant. In a preferred embodiment, the surfactant Ts is synthetic. "Synthetic" means that no biotechnological process was used in the production of the surfactant Ts, i.e., that Ts is not produced by microorganisms, in particular not by bacteria or fungi. 1.1.3.1 Non-ionic surfactant Preferred nonionic surfactants suitable as surfactants are alkoxylated, advantageously ethoxylated, alcohols, which are in particular primary alcohols, preferably with 8 to 18 carbon atoms and preferably an average of 1 to 12 mol of ethylene oxide (“EO”) per mol of alcohol, wherein the alcohol residue may be linear or branched, preferably methyl-branched at the 2-position, or may contain linear and methyl-branched residues in a mixture. However, alcohol ethoxylates with linear residues from native alcohols with 12 to 18 carbon atoms, for example from coconut, palm, tallow, or oleyl alcohol, and an average of 2 to 8 EO per mol of alcohol, are particularly preferred.Preferred ethoxylated alcohols include, for example, C12-C14 alcohols with 3, 4, or 7 EO; C9-C11 alcohols with 7 EO; C13-C15 alcohols with 3, 5, 7, or 8 EO; C12-C18 alcohols with 3, 5, or 7 EO; and mixtures thereof, such as mixtures of C12-C14 alcohols with 3 EO and C12-C18 alcohols with 7 EO. The stated degrees of ethoxylation are statistical averages and may be whole numbers or fractions for a given product. Preferred alcohol ethoxylates exhibit a close homologous distribution. In addition to these nonionic surfactants, it is also possible to use fatty alcohols with more than 12 EOs. Examples include tallow fatty alcohols with 14, 25, 30, or 40 EOs. Nonionic surfactants containing EO and propylene oxide (“PO”) groups together in the molecule can also be used. In this context, it is possible to use block copolymers with EO-PO block units or PO-EO block units, as well as EO-PO-EO copolymers or PO-EO-PO copolymers. Of course, it is also possible to use mixed alkoxylated nonionic surfactants in which EO and PO units are not arranged in blocks but are randomly distributed. Such products are obtained by reacting ethylene oxide and propylene oxide with fatty alcohols. Furthermore, alkyl glycosides can also be used as nonionic surfactants. Another class of preferably used nonionic surfactants, which are used either as the sole nonionic surfactant or in combination with other nonionic surfactants, are alkoxylated, preferably ethoxylated or ethoxylated and propoxylated fatty acid alkyl esters, preferably with 1 to 4 carbon atoms in the alkyl chain, in particular fatty acid methyl esters, as described, for example, in JP S58-217598 A or which are preferably prepared according to the process described in WO 90 / 13533 A1. Non-ionic surfactants of the fatty acid alkanolamide type may also be suitable. The amount of these non-ionic surfactants is preferably not greater than that of the ethoxylated fatty alcohols, and in particular not more than half the amount. Other suitable non-ionic surfactants are polyhydroxy fatty acid amides. These polyhydroxy fatty acid amides are substances that can usually be obtained by reductive amination of a reducing sugar with ammonia, an alkylamine, or an alkanolamine, followed by acylation with a fatty acid, a fatty acid alkyl ester, or a fatty acid chloride. Other examples of non-ionic surfactants include alcohol ethoxylates (“AE” or “AEO”), alcohol propoxylates, propoxylated fatty alcohols (“PFA”), alkoxylated fatty acid alkyl esters such as ethoxylated and / or propoxylated fatty acid alkyl esters, alkylphenol ethoxylates (“APE”), nonylphenol ethoxylates (“NPE”), alkyl polyglycosides (“APG”), alkoxylated amines, fatty acid monoethanolamides (“FAM”), fatty acid diethanolamides (“FADA”), ethoxylated fatty acid monoethanolamides (“EFAM”), polyglycerol esters, glycerol esters, propoxylated fatty acid monoethanolamides (“PFAM”), polyhydroxyalkyl fatty acid amides or N-acyl-N-alkyl derivatives of glucosamine (glucamides, “GA” or fatty acid glucamide, “FAGA”), as well as products available under the trade names “SPAN” and “TWEEN”, and combinations thereof. 1.1.3.2 Anionic surfactant Anionic surfactants that can be used preferably as surfactant TS are, for example, those listed in WO 2014 / 173659 A1, page 3, lines 15 to 25 and those listed on page 3, line 18 to page 4, line 22 of WO 2014 / 118095 A1. It is preferred that the anionic surfactants are of the sulfonate and sulfate type. Suitable anionic surfactants of the sulfonate type are preferably C9-C13 alkylbenzenesulfonates, olefin sulfonates (i.e., mixtures of alkene and hydroxyalkane sulfonates), and also disulfonates, such as those obtained, for example, from C12-C18 monoolefins with a terminal or internal double bond by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acidic hydrolysis of the sulfonation products. Alkane sulfonates obtained from C12-C18 alkanes, for example by sulfochlorination or sulfate oxidation with subsequent hydrolysis or neutralization, are also suitable. Similarly, esters of α-sulfo fatty acids (ester sulfonates) are also suitable, for example, the α-sulfonated methyl esters of hydrogenated coconut, palm kernel, or tallow fatty acids. Other suitable anionic surfactants are sulfated fatty acid glycerol esters. Fatty acid glycerol esters include mono-, di-, and triesters, as well as mixtures thereof, obtained by esterification of a monoglycerol with 1 to 3 mol of fatty acid or by transesterification of triglycerides with 0.3 to 2 mol of glycerol. Preferred sulfated fatty acid glycerol esters are the sulfation products of saturated fatty acids with 6 to 22 carbon atoms, such as caproic acid, caprylic acid, capric acid, myristic acid, lauric acid, palmitic acid, stearic acid, or behenic acid. Preferred alkyl sulfates and alkenyl sulfates are the alkali metal salts, and in particular the sodium salts, of the sulfuric acid half-esters of C12-C18 fatty alcohols, for example, from coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl, cetyl, or stearyl alcohol, or the C10-C20 oxo alcohols (oxo alcohols are alcohols formed by the catalytic hydrogenation of aldehydes from the hydroformylation reaction of olefins with synthesis gas), and such half-esters of secondary alcohols of these chain lengths. Furthermore, alkyl sulfates and alkenyl sulfates of the specified chain length are preferably used, which contain a synthetic straight-chain alkyl radical produced on a petrochemical basis and which exhibit analogous degradation behavior to suitable compounds based on fatty chemical raw materials. From a washing point of view, the C12-C16 alkyl sulfates and C12-C18 alkyl sulfates as well as C14-C18 alkyl sulfates are preferred.2,3-Alkyl sulfates, which are manufactured, for example, according to US 3,234,258 A or US 5,075,041 A and can be obtained as commercial products from Shell Oil Company under the name DAN®, are also suitable anionic surfactants. Sulfuric acid monoesters of straight-chain or branched C7-C20 alcohols ethoxylated with 1 to 6 mol of ethylene oxide (“EO”) are also suitable, such as 2-methyl-branched C9-C11 alcohols with an average of 3.5 mol EO or C12-C18 fatty alcohols with 1 to 4 mol EO. Due to their strong foaming properties, they are used in cleaning compositions only in relatively small quantities, for example, in amounts of 1 to 5 wt%. Other suitable anionic surfactants include the salts of alkylsulfosuccinic acid, also known as sulfosuccinates or sulfosuccinic acid esters, which react with alcohols, preferably fatty alcohols and especially ethoxylated fatty alcohols, to form monoesters and / or diesters of sulfosuccinic acid. Preferred sulfosuccinates contain C8-C18 fatty alcohol residues or mixtures thereof. Particularly preferred sulfosuccinates contain a fatty alcohol residue derived from ethoxylated fatty alcohols. Sulfosuccinates whose fatty alcohol radicals are derived from ethoxylated fatty alcohols with a close homologous distribution are especially preferred in this context. It is also possible to use alkylsuccinic acid and alkenylsuccinic acid, preferably with 8 to 18 carbon atoms in the alkyl / alkenyl chain, or salts thereof. Particularly preferred anionic surfactants are soaps.Saturated and unsaturated fatty acid soaps are also suitable, such as the salts of lauric acid, myristic acid, palmitic acid, stearic acid, (hydrogenated) erucic acid and behenic acid, as well as soap mixtures that are obtained especially from natural fatty acids, for example coconut, palm kernel, olive oil or tallow fatty acid. Anionic surfactants, including soaps, can be in the form of their sodium, potassium, or ammonium salts, as well as soluble salts of organic bases such as mono-, di-, or triethanolamine. Preferably, the anionic surfactants are in the form of their sodium or potassium salts, particularly the sodium salts. Preferred anionic surfactants are sulfates and sulfonates, in particular selected from the group consisting of linear alkylbenzenesulfonates (“LAS”), isomers of LAS, branched alkylbenzenesulfonates (“BABS”), phenylalkanesulfonates, α-olefin sulfonates (“AOS”), olefin sulfonates, alkenesulfonates, alkyl 2,3-diyl bis(sulfates), hydroxyalkylsulfonates, hydroxyalkyldisulfonates, alkyl sulfates (“AS”) such as sodium dodecyl sulfate (“SDS”), fatty alcohol sulfates (“FAS”), sulfates of primary alcohols (“PAS”), alcohol ether sulfates (“AES” or “AEOS” or “FES”, such as alcohol ethoxysulfates or fatty acid ether sulfates) such as sodium dodecyl poly(oxyethylene) sulfate (“SLES”), secondary alkyl sulfonates (“SAS”), paraffin sulfonates (“PS”), ester sulfonates, sulfonated Fatty acid glycerol esters, α-sulfofaticial acid methyl esters (“α-SFMe” or “SES”) such as methyl ester sulfonate (“MES”), alkyl or alkenyl succinic acid, dodecenyl / tetradecenyl succinic acid (“DTSA”), fatty acid derivatives of amino acids,Diesters and monoesters of sulfosuccinic acids or soaps. 1.1.3.3 Cationic surfactant Preferably suitable cationic surfactants are selected from the group consisting of alkyldimethylethanolamine quat (“ADMEAQ”), cetyltrimethylammonium bromide (“CTAB”), dimethyldistearylammonium chloride (“DSDMAC”) and alkylbenzyldimethylammonium, alkylquaternary ammonium compounds, alkoxylated quaternary ammonium compounds (“AQA”) and combinations thereof. 1.1.3.4 Amphoteric surfactants Preferably, amphoteric surfactants suitable as surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one -COO- or -SO3- group in the molecule. Particularly preferred amphoteric surfactants in this context are betaine surfactants such as alkyl or alkylamidopropyl betaine, especially cocamidopropyl betaine. In particular, betaines such as the N-alkyl-N,N-dimethylammonium glycinates, e.g., cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N,N-dimethylammonium glycinate, e.g., cocoacylaminopropyldimethylammonium glycinate, C12-C18-acyldimethylacetobetaine, cocamidopropyldimethylacetobetaine, 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazoline, and sulfobetaines, each with 8 to 18 carbon atoms in the alkyl or acyl group, are preferred. Cocoacylaminoethylhydroxyethylcarboxymethylglycinates are preferred here.A particularly preferred zwitterionic surfactant is N,N-Dimethyl-N-(lauroylamidopropyl)ammoniumacetobetaine, which is known under the INCI name Cocamidopropylbetaine. Other suitable amphoteric surfactants include the group of amphoacetates and ammphodiacetates, in particular, for example, coco- or laurylamphoacetates or diacetates, the group of amphopropionates and ammphodipropionates, and the group of amino acid-based surfactants such as acylglutamates, in particular disodium cocoylglutamate and sodium cocoylglutamate, acylglycinates, in particular cocoylglycinates, and acylsarcosinates, in particular ammonium lauroylsarcosinate and sodium cocoylsarcosinate. Zwitterionic surfactants of the amine oxide type, in particular selected from lauryldimethylamine oxide, N-cocoalkyl-N,N-dimethylamine oxide and N-tallow fatty acid alkyl-N,N-dihydroxyethylamine oxide, preferably lauryldimethylamine oxide, are also suitable. Non-restrictive examples of amphoteric surfactants include betaine, alkyldimethyl betaine, and sulfobetaine. Preferred amphoteric surfactants (TAmph) include betaine, alkyldimethyl betaine, and sulfobetaine. Even more preferred are betaines such as the N-alkyl-N,N-dimethylammonium glycinates, e.g., cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N,N-dimethylammonium glycinate, e.g., cocoacylaminopropyldimethylammonium glycinate, C12-C18-acyldimethylacetobetaine, cocaamidopropyldimethylacetobetaine, 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazoline, and sulfobetaines, each with 8 to 18 carbon atoms in the alkyl or acyl group. Cocoacylaminoethylhydroxyethylcarboxymethylglycinates are particularly preferred. Particularly preferred amphoteric surfactants (TAmphs) are betaine surfactants such as alkyl or alkylamidopropyl betaine, particularly preferably cocamidopropyl betaine as the most preferred betaine surfactant, or amine oxides, in particular selected from lauryldimethylamine oxide, N-cocoalkyl-N,N-dimethylamine oxide and N-tallow fatty alkyl-N,N-dihydroxyethylamine oxide, preferably lauryldimethylamine oxide. The term “cocoamidopropyl betaine” refers in particular to a compound of structural formula (XIII), where R is a saturated or unsaturated alkyl group with 3 to 24 carbon atoms. In structural formula (XIII) the residue RC(=O)- is preferably selected from the fatty acid acyl residues of the following acids: caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, arachidic acid, gadoleic acid. The preferred residue R is an unbranched, saturated alkyl residue with 11 carbon atoms, i.e., the residue RC(=O)- is the fatty acid alkyl residue of lauric acid. The total amount of all glucolipids G and all surfactants Ts in the mixture M provided in step a) of the process according to the invention is preferably selected such that the total weight of all glucolipids G and all surfactants Ts in the mixture M is in the range of 3 wt.% to 85 wt.%, more preferably in the range of 3 wt.% to 60 wt.%, even more preferably in the range of 3 wt.% to 40 wt.%, and most preferably in the range of 3 wt.% to 35 wt.%, in each case based on the total weight of the mixture M. The total amount of all glucolipids G and all surfactants TS in the dispersion D produced in the process according to the invention is preferably selected such that the total weight of all glucolipids G and all surfactants Ts in the dispersion D is in the range of 3 wt.% to 85 wt.%, more preferably in the range of 3 wt.% to 60 wt.%, even more preferably in the range of 3 wt.% to 40 wt.%, and most preferably in the range of 3 wt.% to 35 wt.%, in each case based on the total weight of the dispersion D. The total amount of all glucolipids G and all surfactants TS in the dispersion D produced in the process according to the invention is preferably selected such that the total weight of all glucolipids G and all surfactants Ts in the dispersion D is in the range of 5 wt.% to 60 wt.%, preferably in the range of 10 wt.% to 40 wt.%, in each case based on the total weight of the dispersion D. In cases where the dispersion D is a cosmetic product, the total amount of all glucolipids G and all surfactants Ts in the dispersion D is preferably selected such that the total weight of all glucolipids G and all surfactants Ts in the dispersion D is in the range of 1 wt.% to 30 wt.%, preferably in the range of 1 wt.% to 15 wt.%, in each case based on the total weight of the dispersion D. Dispersion D is characterized by the fact that larger active ingredient capsules can be dispersed more stably in it than in prior art dispersions, such as those in WO 2014 / 173659 A1. 1.1.4 Active ingredient capsules WK The active ingredient capsules WK added in step b) of the process according to the invention, as well as those of the active ingredient capsules WKs comprised of the dispersion D obtained in the process according to the invention, are particularly macroscopic or microscopic, preferably macroscopic. "Macroscopic" means in particular that the diameter of the active ingredient capsules WK is ≥ 3 µm, preferably in the range of 3 µm to 10 µm. "Microscopic" means in particular that the diameter of the active ingredient capsules WK is < 3 µm, preferably in the range of 0.01 µm to < 3 µm, and even more preferably in the range of 0.1 µm to 2 µm. In a further embodiment of the present invention, the particle size and average diameter of the active ingredient capsules WKliegen are in the range of 10 nm to 1000 µm, preferably in the range of 50 nm to 100 µm, more preferably in the range of 2 µm to 40 µm, even more preferably in the range of 4 µm to 15 µm, even more preferably in the range of 5 µm to 10 µm, and even more preferably in the range of 6 µm to 7 µm. The statistical distribution of particle size and average diameter of drug capsules can be narrow, broad, or multimodal. Multimodal distributions can occur when drug capsules of different capsule chemistries are used. In a preferred embodiment, the active ingredient capsules WK comprise a shell S enclosing a core K, wherein preferably at least one active ingredient B is located in the core K. The active ingredient capsules WK, in particular the shell S of the active ingredient capsules WK, preferably comprise urea-formaldehyde and / or melamine-formaldehyde. In one embodiment, the active ingredient capsules WK may comprise microcapsules, meaning that the active ingredient B is then present as microcapsules. "Microcapsules" specifically means that the diameter of the active ingredient B is < 3 µm, preferably in the range of 0.01 µm to < 3 µm, and even more preferably in the range of 0.1 µm to 2 µm. In a preferred embodiment, the active ingredient capsules WK are those that release the at least one active ingredient B by applying pressure and / or shear forces, in particular friction, pressure and / or shear stress, to the active ingredient capsules WK. This is preferred for fragrance active ingredients, wherein these fragrance active ingredients are released in the active ingredient capsules WK by mechanical action (e.g., friction, pressure, shear forces). In addition to or as an alternative to this release mechanism, drug capsules can also be used that release at least one active ingredient B by diffusing B from the outermost shell of the drug capsule. In this process, the sensorially useful active ingredient contained therein is released by diffusion through the outer wall of the capsule. Within the scope of the present invention, preferred active ingredient capsules WK are those that release the active ingredient B by friction. These active ingredient capsules WK preferably comprise melamine formaldehyde. Corresponding commercially available active ingredient capsules WK are available, for example, under the trade names “Aroma Ball Type 1” and “Aroma Ball S-series encapsulates” (formerly Polychrom, South Korea). In a preferred embodiment, the active ingredient capsules W comprise a shell S enclosing a core K. This shell S preferably comprises at least one material selected from the group consisting of polyurethanes, polyamides, polyolefins, polysaccharides, proteins, silicones, lipids, cellulose, modified cellulose, rubber resin, polyacrylates, polyphosphates, polystyrene, polyesters, and polymethyl methacrylate. More preferably, the shell S comprises at least one material selected from the group consisting of melamine-formaldehyde condensates and urea-formaldehyde condensates. The shell S may also comprise similar types of aminoplasts. Most preferably, the shell S comprises melamine-formaldehyde condensate. Active ingredient capsules (WK) obtained by coacervation of gelatin can also be used. The terms “melamine-formaldehyde condensation resin”, “melamine-formaldehyde” and “melamine resin” are used synonymously within the scope of this invention. The terms “urea-formaldehyde condensation resin”, “urea-formaldehyde” and “urea resin” are used synonymously within the scope of this invention. The coacervation of gelatin is particularly preferred for obtaining microcapsules which are used in the process according to the invention as active ingredient capsules WK or as active ingredient B. The production of capsules comprising aminoplasts (which can then be used as active ingredient capsules or active ingredients B) is known to those skilled in the art and is described, for example, in US 3,516,941 A. A typical method for producing capsules comprising gelatin, which can then be used as active ingredient capsules or active ingredients B, is known to those skilled in the art and is described, for example, in US 2,800,457 A. The encapsulation of fragrances for use of the resulting active ingredient capsules in consumer products is described in US 4,145,184 A and US 5,112,688 A. Depending on the technique used, encapsulation can create pore gaps or interstitial openings. Fragrance capsules known in the art and suitable for use in the present invention as active ingredient capsules comprise a wall or shell S, preferably a shell S comprising a three-dimensionally cross-linked network of an aminoplast resin, in particular consisting of a substituted or unsubstituted acrylic acid polymer or copolymer, which is cross-linked with a urea-formaldehyde precondensate or a melamine-formaldehyde precondensate, and particularly preferably consisting of The formation of microcapsules using mechanisms similar to the above mechanism, using (i) melamine-formaldehyde or urea-formaldehyde precondensates and (ii) polymers containing substituted vinyl monomer units with attached proton-donating functional group moieties (e.g., sulfonic acid groups or carboxylic anhydride groups), is disclosed in US 4,406,816 A (2-acrylamido-2-methylpropanesulfonic acid groups), GB 2,062,570 A (styrenesulfonic acid groups) and GB 2,006,709 A (carboxylic anhydride groups). In a particular embodiment of the present invention, the active ingredient capsules also comprise a carrier oil, preferably in the core. The carrier oils are hydrophobic materials that are miscible with the active ingredients B used in the present invention, in particular with volatile active ingredients B. Suitable oils are those that have an appropriate affinity for active ingredient B. If active ingredient B is a perfume, suitable carrier oils include, but are not limited to, at least one oil selected from the group consisting of triglyceride oil, mono- and diglycerides, mineral oil, silicone oil, diethyl phthalate, polyalphaolefins, castor oil, and isopropyl myristate. Preferably the oil is a triglyceride oil, particularly preferably a caprylic / capryl triglyceride oil. 1.1.5 Separation aid AD The active ingredient capsule WK, in particular the shell S of the active ingredient capsule WK, may further comprise a separation aid AD, which is preferably covalently bonded. The separation aid ADist is preferably a polysaccharide, which preferably has a β-1,4-linked backbone. Preferably, the polysaccharide is selected from cellulose, a cellulose derivative, or the polysaccharide is another β-1,4-linked polysaccharide with an affinity for cellulose, such as polymannan, polyglucan, polyglucomannan, polyxyloglucan, and polygalactomannan, or a mixture thereof. The polysaccharide can also be selected from the group consisting of polyxyloglucan (also referred to as "xyloglucan") and polygalactomannan (also referred to as "galactomannan"). Preferred polymannans are acetylated polymannan polysaccharides. Particularly as separation aids, preferred polysaccharides are selected from locust bean gum, tamarind bean gum, xyloglucan, non-ionic guar gum, cationic starch, and mixtures thereof. Locust bean gum is most preferred as a separation aid. Preferably, the backbone of the polysaccharide used as a separation aid has only β-1,4-linkages. Optionally, the polysaccharide used as a separation aid AD may exhibit additional linkages beyond the β-1,4 linkages, such as β-1,3 linkages. Thus, further linkages are optionally present. Polysaccharides with polysaccharide backbones containing (whether terminal or within the polysaccharide chain) a material or chemical structure that is not a saccharide ring can also be used as separation aids AD. The polysaccharide ADein used as a separation aid can be linear or branched. Many naturally occurring polysaccharides exhibit at least some degree of branching, or at least some saccharide rings are present as attached side groups on a polysaccharide backbone (which are preferably not taken into account when determining the degree of substitution). Preferably, the polysaccharide used as a separation aid AD is present in a proportion in the range of 0.1 wt.% to 10 wt.%, based on the total weight of the active ingredient capsules WK. The separation aid AD, which is preferably a polysaccharide, is bound to the particles, in particular the active ingredient capsules WK, in particular by a covalent bond, by entanglement or by adsorption, preferably by a covalent bond or entanglement and particularly preferably by a covalent bond. The term "entanglement" here refers to the adsorption of the separation aid AD during polymerization and as the particle size increases, onto the particle, particularly the drug capsule WK. A portion of the adsorbed separation aid AD is then buried within the particle, particularly the drug capsule WK. Therefore, at the end of polymerization, a portion of the separation aid AD is trapped and bound within the polymer matrix of the particle, particularly the drug capsule WK, while the remainder escapes unimpeded. If the particle, particularly the drug capsule WK, is present in the dispersion D, the continuous phase, particularly the aqueous phase, of D can be contacted or extend into it. Adsorption here refers specifically to the adsorption of the separation aid AD onto the surface of the particle, particularly the active ingredient capsule WK; such adsorption can occur, for example, due to hydrogen bonds, van der Waals forces, or electrostatic attraction between the separation aid AD and the particle, particularly the active ingredient capsule WK. In this embodiment, the separation aid AD therefore adheres mainly to the surface of the particle, particularly the active ingredient capsule WK, and does not distribute itself to any significant extent within the particle, particularly the active ingredient capsule WK. This differs from graft copolymers, where, for example, a polysaccharide can be grafted along the length of a polymer chain. A particle, in particular an active ingredient capsule WK, formed from a graft copolymer would therefore contain polysaccharides throughout its interior and on its surface. While this type of particle can be used within the scope of the present invention, it is less preferred as an active ingredient capsule WK. Thus, the particle formed as an active ingredient capsule WK using a polysaccharide as a deposition aid according to the method of the invention can be thought of as a "hairy particle," distinct from a graft copolymer. This feature of the invention offers the manufacturer significant cost-saving opportunities, as much less deposition aid is required to achieve the same level of activity as systems using polysaccharide copolymers. In a preferred embodiment, the deposition aid AD is located in the outermost part of the shell S of the active ingredient capsule WK, wherein the shell S comprises melamine-formaldehyde polymer and / or urea-formaldehyde polymer, preferably melamine-formaldehyde polymer, and more preferably the shell S consists of melamine-formaldehyde polymer and / or urea-formaldehyde polymer, and more preferably of melamine-formaldehyde polymer. The shell S has a thickness in the range of 5 nm to 20 nm. In a preferred embodiment of the present invention, a polymer P1 is used as a separation aid AD, which is preferably selected from polyesters of terephthalic acid and other aromatic dicarboxylic acids with dirt-removing properties. These are so-called “polyester soil-release polymers”. The polymer P1 used is preferably the so-called PEG / POET (polyethylene glycol / polyoxyethylene terephthalate) polyesters, PET / POET (polyethylene terephthalate / polyoxyethylene terephthalate), and PET / PEG (polyethylene terephthalate / polyethylene glycol) polyesters. PET / POET is particularly preferred. In a further preferred embodiment, the polymer P1 has at least one mole of free OH group per mole of polymer to enable covalent bonding to the reactive dye(s) used in particular. The polymer P1 particularly preferably has at least two free OH groups. Preferably, the OH groups are the end groups of the polymer P1. The polymer P1 can also have groups selected from oxyalkyleneoxy group [-O(CH2)tO-] or polyoxyalkyleneoxy group [-O(CH2)w-]sO-, where t, w, s are independent integers. Preferably, the oxyalkylenoxy group is selected from the following groups: oxy-1,3-propylenoxy [O-CH2CH2CH2O-], oxy-1,2-ethyleneoxy [-OCH2CH2O-]. One or more of the CH2 groups of the oxyalkylenoxy can be substituted by C1 to C4 alkyl groups, so that oxy-1,2-propylenoxy {-OCH2[CH(CH3)]O-} is also a preferred oxyalkylenoxy group. A polyoxyalkylenoxy group facilitates the water solubility of the polymer P1. Preferably, the polyoxyalkylenoxy group is selected from: polyoxy-1,2-propylenoxy {-O(CH2[CH(CH3))-sO-; polyoxy-1,3-propylenoxy [O-CH2CH2CH2-]sO-; and polyoxy-1,2-ethyleneoxy [O-CH2CH2-]sO-. The polyoxyalkylenoxy group can be a mixture of different oxyalkylenoxy groups. Therefore, different types of polyoxyalkylenoxy can be present in polymer P1. The polymer P1 can also include a 1,4-phenyldicarboxylate group. This preferably has the structure -OC(=O)-phenyl ring-C(=O)-O-. The two carboxylate groups are in the para position to each other on the phenyl ring. The polymer P1 preferentially has a structure of the chemical formula (I)*: In the chemical formula (I)*: R2 is selected from CH3, H, preferably R2 = Hb = 2 or 3, preferably b = 3. y = an integer in the range 2 to 100, preferably an integer in the range 5 to 50. n and m are independently of each other integers in the range 1 to 100, preferably each an integer in the range 2 to 30. The units enclosed by “n” and “m” can occur alternately or in blocks in polymer P1 of chemical structure (1)*. The terminal (end) groups of polymer P1 of chemical structure (1)* are -(CH2)bOH. Another preferred structure of polymer P1 is chemical structure (II)*: In chemical formula (II)*, R1 and R2 are each independently selected from (i), (ii), (iii), (iv), where (i) is preferred, (i) X-(OC2H4)n-(OC3H6)m-(*), wherein X = C1-4-alkyl, preferably X = methyl; (ii) X-(OC3H6)m-(OC2H4)n-(*), wherein X = C1-4-alkyl, preferably X = methyl; (iii) X-(OC3H6)m-(*), wherein X = C1-4-alkyl, preferably X = methyl; (iv) X-(OC2H4)n-(*), wherein X = C1-4-alkyl, preferably X = methyl; wherein the -(OC2H4) groups and the (OC3H6) groups in residues (i) and (ii) are present in blocks or mixed (= not in blocks), preferably in blocks, where “(*)” denotes the bond to the singly bonded oxygen of the respective “COO” group in structure (II)*, n = an integer in the range of 12 to 120, preferably 40 to 50, m = an integer in the range of 1 to 10, preferably 2 to 7, a = an integer in the range of 4 to 9. Polymers P1, especially those of chemical structure (1)* or (II)**, can be synthesized by various routes, for example by an esterification reaction of dimethyl terephthalate with ethylene glycol and polyethylene glycol. This reaction is described by F. Khorshahi, S. Lin, A. Jensen, D. Kwoh, Polymer Bulletin 1992, 28, 451–458. Alternatively, polymers P1, especially those of chemical structure (1)*, can be obtained by the direct esterification of terephthalic acid with ethylene glycol and / or propylene glycol and polypropylene glycol, or by transesterification of a polyethylene terephthalate with a polyethylene glycol or polypropylene glycol. It is preferred that the mean molecular weight of polymer P1, in particular the mean molecular weight of polymers P1 of chemical structure (1)* or (II)**, is in the range of 1000 g / mol to 50000 g / mol, preferably in the range of 1000 g / mol to 15000 g / mol, more preferably from 2000 g / mol to 10000 g / mol. 1.1.7 Perfume A preferred active ingredient B is a perfume PF or a perfume mixture MPF. The components of the perfume PF can be selected from materials of both natural and synthetic origin. Such materials can be either single compounds or mixtures. Specific examples of such compounds or mixtures can be found in the literature, e.g., in i. George A. Burdock, “Fenaroli's Handbook of Flavor Ingredients,” 6th edition, 2009, CRC Press ; ii. Morris Boris Jacobs, “Synthetic Food Adjuncts,” 2013, Literary Licensing LLC ; iii. Steffen Arctander, “Perfume and Flavor Chemicals”, 1969, Montclair, NJ (USA). These substances are well known to experts in the field of perfuming, flavoring and / or aromatizing consumer goods; that is, they give a smell and / or aroma or taste to conventionally perfumed or aromatized consumer goods, or they change the smell and / or taste of said consumer goods. For the purposes of this invention, "perfume" refers not only to the finished fragrance of a product, but also to selected components of that fragrance, especially those that can be easily lost, such as the so-called top notes. “Top notes” are defined by W.A. Poucher, Journal of the Society of Cosmetic Chemists 1955, 6, 80–94. Examples of known top notes are citrus oils, linalool, linalyl acetate, lavender, 2,6-dimethyl-7-octen-2-ol (“dihydromyrcenol”), rose oxide, and cis-3-hexanol. Top notes typically comprise 15–25 wt.% of a perfume composition, based on the total weight of the perfume composition, and particularly in embodiments of the invention in which active ingredient B contains an increased proportion of top notes, it is provided that active ingredient B comprises at least 20 wt.% perfume PF, based on the total weight of all active ingredients B contained within the active ingredient capsule W. Some or all perfumes PF or the precursors of perfumes PF may be encapsulated. Typical perfume components for which encapsulation is advantageous include those with a relatively low boiling point, preferably those with a boiling point of less than 300 °C, preferably 100 °C to 250 °C, and precursors of such perfumes. It is also advantageous to encapsulate perfume components with a low CLog P value (i.e., those that dissolve in water), preferably with a CLog P value of less than 3.0. These substances with relatively low boiling points and relatively low CLog P are referred to as "delayed blooming" perfume ingredients and include the following substances ("List I"): allyl caproate, amyl acetate, amyl propionate, anisaldehyde, anisole, benzaldehyde, benzyl acetate, benzyl acetone, benzyl alcohol, benzyl formate, benzyl isovalerate, benzyl propionate, β-γ-hexenol, camphor gum, (R)-(-)-carvone (CAS No.: 6485-40-1), (S)-(+)-carvone (CAS No.: 2244-16-8), cinnamyl alcohol, cinnamal formate, cis-jasmon, cis-3-hexenyl acetate, cumin alcohol, cyclic C ("2,4-dimethyl-3-cyclohexene-1-carbaldehyde"; CAS No.: 68039-49-6). Dimethyl benzyl carbinol, dimethyl benzyl carbinol acetate, ethyl acetate, ethyl acetoacetate, ethyl amyl ketone, ethyl benzoate, ethyl butyrate, ethylhexyl ketone, ethyl phenyl acetate, eucalyptol, eugenol, fenchyl acetate, floracetate (= tricyclodecenyl acetate; CAS No.: 5413-60-5), fruten (Tricyclodecenylpropionate; CAS no.: 17511-60-3), Geraniol, Hexenol, Hexenylacetat, Hexylacetat, Hexylformiat, hydratropic alcohol (= 2-Phenylpropan-1-ol; CAS-Nr.: 1123-85-9), Hydroxycitronellal, Indon, Isoamylalkohol, Isomenthon, Isopulegylacetat, Isochinolon, Ligustral, Linalool, Linalooloxid, Linalylformiat, Menthon, Menthylacetphenon, Methylamylketon, Methylanthranilat, Methylbenzoat, Methylbenylacetat, Methyleugenol, Methylheptenon, Methylheptincarbonat, Methylheptylketon, Methylhexylketon, Methylphenylcarbinylacetat, Methylsalicylat, Methyl-N-methylanthranilat, Nerol, Octalacton, Octylalkohol, p-Kresol, p-Kresolmethylether, p-Methoxyacetophenon, p-Methylacetophenon, Phenoxyethanol, Phenylacetaldehyd, Phenylethylacetat, Phenylethylalkohol, Phenylethyldimethylcarbinol, Prenylacetat, Propylbornat, Pulegon, Rosenoxid, Safrol, 4-Terpinenol, α-Terpinenol und / oder Viridin. If non-encapsulated or “free” perfume components are used, hydrophobic perfume components with a CLogP above 3 are preferable. As used here, the term “CLogP” refers to the calculated decadic logarithm of the octanol / water partition coefficient (P). The octanol / water partition coefficient of a perfume raw material (PRM) is the ratio between its equilibrium concentrations in octanol and water, especially at 25 °C. Since this measure is a ratio of the equilibrium concentration of a PRM in a nonpolar solvent (octanol) to its concentration in a polar solvent (water), CLogP is also a measure of the hydrophobicity of a material - the higher the CLogP value, the more hydrophobic the material. CLogP values ​​can be easily calculated using a program called "CLOGP," available from Daylight Chemical Information Systems Inc., Irvine, California, USA. Octanol / water partition coefficients are described in more detail in US 5,578,563 A. Perfume ingredients with a CLogP > 3 include (“List II”): Iso E super (= at least one tetramethylacetyloctahydronaphthalene, e.g., at least one selected from the substances with the following CAS Nos.: 54464-57-2; 68155-66-8; 68155-67-9), citronellol, ethyl cinnamate, bangalol, 2,4,6-trimethylbenzaldehyde, hexyl cinnamaldehyde, 2,6-dimethyl-2-heptanol, diisobutylcarbinol, ethyl salicylate, phenethyl isobutyrate, ethylhexyl ketone, propylamyl ketone, dibutyl ketone, heptyl methyl ketone, 4,5-dihydrotoluene, caprylaldehyde, citral, geranial, isopropyl benzoate, cyclohexanepropionic acid, campholaldehyde, caprylic acid, caprylic alcohol, cuminaldehyde. 1-Ethyl-4-nitrobenzene, heptyl formate, 4-iso-propylphenol, 2-iso-propylphenol, 3-iso-propylphenol, allyl disulfide, 4-methyl-1-phenyl-2-pentanone, 2-propylfuran, allyl caproate, styrene, iso-eugenyl methyl ether, indonaphthene, diethyl suberate, menthone [as a racemic mixture (CAS No.: 89-80-5), but also as pure (2S,5R)-(-)-Menthon („L-Menthon“; CAS-Nr.: 14073-97-3) und als reines (2R,5S)-(+)-Menthon („D-Menthon“; CAS-Nr.: 3391-87-5)], p-Kresylisobutyrat, Butylbutyrat, Ethylhexanoat, Propylvalerat, n-Pentylpropanoat, Hexylacetat, Methylheptanoat, trans-3,3,5-Trimethylcyclohexanol, 3,3,5-Trimethylcyclohexanol, Ethyl-p-anisat, 2-Ethyl-1-hexanol, Benzylisobutyrat, 2,5-Dimethylthiophen, iso-Butyl-2-butenoat, Caprylnitril, γ-Nonalacton, Nerol, trans-Geraniol, 1-Vinylheptanol, Eukalyptol, 4-Terpinenol, Dihydrocarveol, Ethyl-2-methoxybenzoat, Ethylcyclohexancarboxylat, 2-Ethylhexanal, Ethylamylcarbinol, 2-Octanol, Ethylmethylphenylglycidat, Diisobutylketon, Cumaron, Propylisovalerat, iso-Butylbutanoat, iso-Pentylpropanoat, 2-Ethylbutylacetat, 6-Methyltetrahydrochinolin, Eugenylmethylether, Ethyldihydrocinnamat, 3,5-Dimethoxytoluol, Toluol, Ethylbenzoat, n-Butyrophenon, α-Terpineol, Methyl-2-methylbenzoat, Methyl-4-methylbenzoat, Methyl-3-methylbenzoat, sec-Butyl-n-butyrat, 1,4-Cineol, Fenchylalkohol,Pinanol, cis-2-Pinanol, 2,4-Dimethylacetophenon, iso-Eugenol, Safrol, Methyl-2-octynoat, o-Methylanisol, p-Kresylmethylether, Ethylanthranilat, Linalool, Phenylbutyrat, Ethylenglykoldibutyrat, Diethylphthalat, Phenylmercaptan, Cuminalkohol, 7-Methylchinolin, 6-Methylchinolin, 4-Methylchinolin, 2-Ethylbenzaldehyd, 4-Ethylbenzaldehyd, o-Ethylphenol, p-Ethylphenol, m-Ethylphenol, (+)-Pulegon, 2,4-Dimethylbenzaldehyd, iso-Xylaldehyd, Ethylsorbat, Benzylpropionat, 1,3-Dimethylbutylacetat, iso-Butylisobutanoat, 2,6-Xylenol, 2,4-Xylenol, 2,5-Xylenol, 3,5-Xylenol, Methylcinnamat, Hexylmethylether, Benzylethylether, Methylsalicylat, Butylpropylketon, Ethylamylketon, Hexylmethylketon, 2,3-Xylenol, 3,4, Xylenol, Cyclopentadenanolid und Phenylethyl-2-phenylacetat., If at least one perfume PF is used as active ingredient B in the context of the present invention, it is advantageous and preferred that four or more, preferably five or more, more preferably six or more or even seven or more different perfume components from the above-mentioned list of delayed-blooming perfumes (“List I”) and / or four or more, preferably five or more, more preferably six or more or even seven or more different perfume components from the above-mentioned list of perfume components with a ClogP above 3 (“List II”) are present in the perfume. 1.1.6 Active ingredient B The active ingredient B is not further restricted and can be selected depending on the application of the dispersion D. Preferably, it is selected from the group consisting of: perfumes, insect repellents, essential oils; menthol-containing fragrances and aromatherapy active ingredients; humectants and / or emollients for skin and / or hair, comprising mineral oil, petrolatum, silicone oil, comprising dimethyl polysiloxane, lauryl and myristyl lactate; anti-dandruff agents, which are in particular selected from the group consisting of zinc salts, in particular zinc pyrithione, zinc sulfate and hydrates thereof; piroctone olamine (CAS number: 68890-66-4), selenium sulfide, azole antimicrobial agents, in particular climbazole; silicones, which are in particular selected from the group consisting of polyalkylsiloxanes, polyarylsiloxanes, polyalkylarylsiloxanes, polyethersiloxane copolymer, aminosilicones, silicone rubbers, cross-linked Silicone elastomers, cationic polymers, which in particular is a cationic guar gum derivative, preferably guar hydroxypropyltrimonium chloride. Preferably, the active ingredient B, which is enclosed by the active ingredient capsule W, is a skin active ingredient or an odorant active ingredient and / or a volatile active ingredient. Sensory agents can also have benefits for hair and / or hard surfaces and / or textiles. Suitable volatile active ingredients include perfumes, insect repellents, essential oils, fragrances such as menthol and aromatherapy ingredients, preferably perfumes. Mixtures of volatile active ingredients can be used. The total amount of active ingredient B is preferably 0.01 wt.% to 10 wt.% (wt.% is abbreviated as "wt.%" in the context of the invention), more preferably 0.05 wt.% to 5 wt.%, even more preferably 0.1 to 4.0 wt.%, most preferably 0.15 wt.% to 4.0 wt.%, based on the total weight of the active ingredient capsule WK. According to the invention, active ingredient B can be an encapsulated or unencapsulated volatile active ingredient. If the volatile active ingredient is a perfume, the perfumes described below are suitable for use as an encapsulated volatile active ingredient and also as a free perfume component. 1.1.8 Insect repellents IR Another preferred active ingredient B is an insect repellent IR (also referred to as “insect repellent” or “insect repellent”). Chemically speaking, most repellent active ingredients belong to one of four groups: amides, alcohols, esters or ethers. Suitable for use as a repellent in the present invention are liquids or solids with a relatively low melting point and a boiling point above 150 °C, preferably liquids. They evaporate slowly at room temperature. Ideally, the insect repellent should be classified as a type of perfume (ideally, the component should fall into both classes). The most commonly used insect repellents include: DEET (N,N-Diethyl-m-toluamide), lemon eucalyptus (Corymbia citriodora) essential oil and its active ingredient p-menthane-3,8-diol (PMD), icaridin (CAS No.: 119515-38-7; also known as picaridin, D-limonene, Bayrepel and KBR 3023), nepetalactone (also known as "catnip oil"), citronella oil, permethrin, neem oil and bog myrtle oil (oil from Myrica gale). Preferred insect repellents from natural sources include: Achillea alpina (e.g., extracts of Achillea alpina leaves), α-terpinene, basil oil (Ocimum basilicum oil), Callicarpa americana (e.g., extracts of Callicarpa americana leaves), camphor, carvacrol, castor oil (Ricinus communis), catnip oil (Nepeta species), cedarwood oil (Cedrus atlantica), celery extract (Apium graveolens), cinnamon (Cinnamomum zeylanicum, leaf oil), citronella oil (Cymbopogon flexuosus), clove oil (Syzygium aromaticum), eucalyptus oil (70%+ eucalyptol, also known as cineole), fennel oil (Foeniculum vulgare), garlic oil (Allium sativum), geranium oil (also known as Pelargonium graveolens), and lavender oil. (Lavandula officinalis), lemon eucalyptus essential oil (Corymbia citriodora) and its active ingredient p-menthane-3,8-diol (“PMD”), calendula oil (Calendula officinalis), marigold oil (Tagetes species),Marjoram (Origanum majorana as an insect repellent against Tetranychus urticae and Eutetranychus orientalis), neem oil (Azadirachta indica), oleic acid, peppermint (Mentha x piperita), pennyroyal (Mentha pulegium), pyrethrum (from Tanacetum species and Chrysanthemum species, especially Chrysanthemum cinerariifolium and Tanacetum coccineum), rosemary oil (Rosmarinus officinalis), lantana (Lantana, especially Lantana camara, as an insect repellent against Helopeltis theivora), Millettia pinnata (also especially as an insect repellent against Helopeltis theivora), Solanum villosum berry juice, tea tree oil (Melaleuca alternifolia), and thyme (Thymus species) and mixtures thereof. Preferred encapsulated insect repellents are mosquito repellents available from Celessence, Rochester, England. Celessence Repel contains the active ingredient Saltidin™ and Celessence Repel Natural contains the active ingredient Citrepel™ 75. Saltidin is a synthetic molecule originally developed by Bayer Corporation. Citrepel is made from eucalyptus oil and has a high PMD content. A preferred non-encapsulated insect repellent is Citriodiol™ from Citrefine. 1.1.9 Other classes of active ingredients B The active ingredient B may also be selected from the group of menthol-containing fragrances and aromatherapy active ingredients, preferably selected from essential oils such as clary sage, eucalyptus, geranium, lavender, mace extract, neroli, nutmeg, spearmint, violet leaves and valerian. The active ingredient B may also be selected from the group of humectants and / or emollients for skin and / or hair, preferably selected from mineral oil, petrolatum, lauryl and myristyl lactate, silicone oil, wherein dimethyl polysiloxane is a preferred silicone oil. Active ingredient B may also be an anti-dandruff agent, specifically selected from the group consisting of zinc salts, in particular zinc pyrithione, zinc sulfate and their hydrates. It may also be selected from the group consisting of piroctone olamine, selenium sulfide, and azole antimicrobial agents, in particular climbazole. In embodiments of the present invention in which the active ingredient B comprises an anti-dandruff agent, it is preferred that the proportion of all anti-dandruff agents, based on the total weight of all active ingredients B used in the process or of active ingredients B comprised of the dispersion D, is 0.1 wt.% to 5 wt.%. The active ingredient B may also be a silicone, which is specifically selected from the group consisting of polyalkylsiloxanes, polyarylsiloxanes, polyalkylarylsiloxanes, polyethersiloxane copolymers, aminosilicones, silicone rubbers, cross-linked silicone elastomers. In embodiments of the present invention in which the active ingredient B comprises a silicone, it is preferred that the proportion of all silicones, based on the total weight of all active ingredients B used in the process or of active ingredients B comprised of the dispersion D, is 0.01 wt.% to 10 wt.%. The active ingredient B can also be a cationic polymer for hair care, selected in particular from cationic cellulose and cationic guar derivatives, preferably comprising a cationic guar gum derivative, preferably guar hydroxypropyltrimonium chloride. Such cationic polymers are commercially available, for example, from Rhone-Poulenc in the JAGUAR brand series: 1. JAGUAR C13S, which has a low degree of substitution of the cationic groups and a high viscosity; 2. JAGUAR C15, with a medium degree of substitution and a low viscosity; 3. JAGUAR C17 (high degree of substitution, high viscosity); 4. JAGUAR C16, a hydroxypropylated cationic guar derivative with a low proportion of substituent groups and cationic quaternary ammonium groups; 5. JAGUAR 162, a highly transparent guar with medium viscosity and a low degree of substitution. Particularly preferred cationic polymers are JAGUAR C13S, JAGUAR C15, JAGUAR C17, JAGUAR C16, and JAGUAR C162. In embodiments of the present invention in which the active ingredient B comprises a cationic polymer, it is preferred that the proportion of all cationic polymers, based on the total weight of all active ingredients B used in the process or of active ingredients B comprised by the dispersion D, is 0.01 wt.% to 10 wt.%, in particular 0.01 wt.% to 5 wt.%, preferably 0.05 wt.% to 1 wt.%, more preferably 0.08 wt.% to 0.5 wt.%. If, in particular in a shampoo composition or a hand dishwashing liquid composition according to the invention, a cationic polymer is present, it is preferred that the cationic polymer is present as an emulsion particle with a mean diameter (D3,2 measured by light scattering using a Malvern particle size meter) of 2 µm or less. 1.2 Step b) At the end of step a), a mixture M is obtained. In step b), the active ingredient capsules WK are added to this, resulting in a dispersion D. It was found that the glucolipids stabilize the dispersion D obtained in step b) better than, for example, the rhamnolipids or sophorolipids when the respective substance is added in the same quantity. This results in a more homogeneous and stable dispersion D, since the active ingredient capsules do not settle as quickly in dispersion D as in dispersions obtained according to the prior art, WO 2014 / 173659 A1. However, this effect is only achieved to this advantageous extent if the mixture M is provided first and then the active ingredient capsules WKzu M are added. Preferably, in step a) the mixture M is provided in a container C and in step b) the active ingredient capsules WKzu M are added to the container C. Even more preferably, the mixture M is agitated during the addition of WKzu M, in particular by stirring. This results in thorough mixing and homogenization of the active ingredient capsules WKin M, and a homogeneous dispersion D is obtained. 2. Dispersion D The present invention also relates to a dispersion D obtained in the process according to the invention. It also relates to the use of the dispersion D as a shampoo, textile detergent, or dishwashing detergent, in particular as a hand dishwashing detergent. The dispersion D according to the invention, in particular if it is a shampoo, a textile detergent or a dishwashing detergent, in particular a hand dishwashing detergent, is preferably aqueous, i.e. it has as its main component water or an aqueous solution or a lyotropic liquid crystalline phase, in particular water as its main component. Suitablely, the dispersion D contains 50 wt.% to 98 wt.%, preferably 60 wt.% to 90 wt.% water, based on the total weight of the dispersion D. The pH value of the water in the dispersion D is preferably in the range of 3 to 9, more preferably in the range of 4 to 8, more preferably in the range of 5.5 to 7.5, more preferably in the range of 6.0 to 7.0, measured at 25 °C. Dispersion D is particularly suitable for washing in water with high water hardness, preferably greater than 5 °FH, preferably greater than 40 °FH, even better greater than 90 °FH, where “1 °FH” corresponds to 10 µg CaCO3 per 1 liter of water. The dispersion D according to the invention preferably does not include builders (framework materials), but may include them in a less preferred embodiment. Dispersion D may include further components, in particular selected from the following items i. to iv.: i. Vegetable oils: peanut oil, cannola oil, castor oil, cocoa butter, coconut oil, corn oil, cottonseed oil, olive oil, palm kernel oil, rapeseed oil, safflower oil, sesame oil and soybean oil; ii. Esters: butyl myristate, cetyl palmitate, decyl oleate, glyceryl laurate, glyceryl ricinoleate, glyceryl stearate, glyceryl isostearate, hexyl laurate, isobutyl palmitate, isocetyl stearate, isopropyl isostearate, isopropyl laurate, isopropyl linoleate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, propylene glycol monolaurate, propylene glycol ricinoleate, propylene glycol stearate and propylene glycol isostearate; iii. Animal fats: Acetylated lanolin alcohols, lanolin, lard, mink oil and tallow; iv. Fatty acids and alcohols: Behenic acid, palmitic acid, stearic acid, behenyl alcohol, cetyl alcohol, eicosanyl alcohol and isocetyl alcohol; v.Active ingredients in handwashing and textile cleaning compositions that are particularly suitable for suspension, such as opacifiers and visual indicators, either with or without embedded functional ingredients and other ingredients, antimicrobial agents; vi. polyester-based dirt-dissolving polymers, hydrotropes, opacifiers, dyes, enzymes, other surfactants such as non-ionic, cationic and / or amphoteric surfactants, plasticizers, polymers to prevent re-soiling, bleaching agents, bleach activators and bleaching catalysts, antioxidants, pH regulators and buffers, thickeners, external structuring agents for rheology modification and visual indicators known to those skilled in the art. The enzymes may be selected, for example, from proteases (e.g., those described in WO 2016 / 146497 A1), α-amylases, cellulases, lipases, peroxidases / oxidases, pectate lyases, cutinases and mannanases, or mixtures thereof. Enzymes can also be those described in WO 2012 / 010405 A1. Dispersion D can be in the form of a gel or liquid. Unless otherwise stated, all percentages (%) are mass percentages. 3. Use In a third aspect, the invention also relates to the use of dispersion D as shampoo, textile detergent or dishwashing liquid, in particular as hand dishwashing liquid. The at least one glucolipid G can also be used in the dispersion D according to the invention, wherein the dispersion D according to the invention is used as a hand wash to give the consumer a sensory impression of hand mildness, preferably the sensory impression of hand mildness also remains after the subsequent drying of the hands after completion of the hand washing process. In one embodiment, the handwashing detergent is a hand dishwashing composition or a liquid detergent composition for handwashing. In another embodiment, the hand washing detergent is a liquid detergent composition, preferably an aqueous detergent composition, particularly for textiles. 4. Methods for treating a substrate In a fourth aspect, the present invention relates to a method for treating, preferably washing and / or rinsing, a substrate S using a washing solution, comprising generating a washing solution by mixing the dispersion D according to the invention with water and contacting the washing solution with the substrate S. In a preferred embodiment of the fourth aspect, the present invention relates to a method for treating a substrate S using a washing solution, comprising generating a washing solution by mixing the dispersion D according to the invention with water in a container, preferably a bathtub, a bucket or a sink, and contacting the washing solution with the substrate S. The substrate S is preferably the user's body or a fabric, nonwoven, or hard surface, preferably dishes, and the substrate S is preferably dishes that are washed by hand. The substrate S is selected in particular from an object and a part of the human or animal body; preferably S is an object. Preferred objects are selected from fabrics, nonwovens, objects with hard surfaces, preferably tableware. The dispersion D according to the invention can also be used for personal care, e.g. as shampoo. Preferred parts of the human or animal body are then teeth, hair or skin. The method according to the second aspect of the invention is preferably one in which S is an object which is washed and / or rinsed by hand, wherein the object is preferably selected from fabrics, nonwovens, objects with hard surfaces, and most preferably is tableware. The pH value of the water in the washing solution is preferably in the range of 3 to 9, more preferably in the range of 4 to 8, more preferably in the range of 5.5 to 7.5, more preferably in the range of 6.0 to 7.0, measured at 25 °C. Dispersion D is particularly suitable for washing in water with high water hardness, preferably greater than 5 °FH, preferably greater than 40 °FH, even better greater than 90 °FH, where “1 °FH” corresponds to 10 µg CaCO3 per 1 liter of water. The dispersion D preferably does not include builders (framework materials), but may include them in a less preferred embodiment. The substrate S is preferably selected from an object and a part of the human or animal body, wherein S is preferably an object. pH values ​​are measured at 25 °C within the scope of the present invention, unless otherwise specified. The following examples describe the present invention by way of example, without limiting the invention, the scope of which is evident from the entire description and the claims, to the embodiments mentioned in the examples. Examples: Various dispersions of an encapsulated active ingredient in an anionic surfactant in mixture with rhamnolipids (comparative examples) or glucolipids (inventive examples) are investigated as described below. The following materials were used in the experiments: Glucolipid (“GL”) is obtained as described in Examples 1 to 3 of WO 2019 / 154970 A1. It was used as a 50 wt% solution. Rhamnolipid (“RL”) is di- or mono-rhamnolipid or a 1:1 mixture of di- and mono-rhamnolipid. Di-rhamnolipids (“diRL”) are obtained according to Example 1 of EP 3 061 442 A1. They are used as a 50 wt% aqueous solution. Mono-rhamnolipids (“monoRL”) are obtained according to Example 2 of EP 3 061 442 A1. They are used as a 75 wt% aqueous solution. Sodium lauryl ether sulfate (“SLES 1EO”) is used as the anionic surfactant (28 wt%; Texapon N 701, BASF). Alternatively, LAS (linear alkylbenzenesulfonate; CAS number 68411-30-3) is used as the anionic surfactant. Cocoamidopropyl betaine (“CAPB”; TEGO®Betaine F 50, 38 wt%), Evonik Industries AG, is used as an amphoteric surfactant. Cross-linked polyacrylic acid (Carbopol 980; Lubrizol) is used as a rheology modifier. Guarhydroxypropyltrimonium chloride is used as the cationic polymer (Jaguar C14S; Rhodia). A polydimethylsiloxane polymer is used as the silicone oil (100% active; Xiameter PMX-200 Silicone Fluid 1cSt). The active ingredient capsules used are melamine formaldehyde capsules with an aroma substance (“Aroma Ball Type 1 and Aroma Ball S-series; Polychrom; Korea”) that release the active ingredient upon contact with friction. Alternatively, capsules based on gelatin and gum arabica (250 mm to 3000 µm diameter) that release the active ingredient upon application of shear force are used (captivates hc encapsulates from Ashland). The preservative used is 1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (CAS number: 6440-58-0; DMDM ​​Hydantoin; “Glydant”; Lonza). Experimental series: Experiment series I: In a 50 ml Falcon container, 50 ml of the following compositions are mixed according to the protocols. The proportions of the different components are as follows: Component(s) Used proportions in weight percent** Anionic surfactant***963 Biosurfactant*369 Carbopol 9800.4 Perfume 0.7 Jaguar C14S0.2 CAPB1.6 Silicone oil 0.75 Active ingredient capsule 0.3 DMDM Hydantoin0.1 NaCl 0.5 or 1 or 1.5 or 2 NaOH0.1 Water content 100 wt.% * In the inventive examples, GL is used as the biosurfactant; in the comparative examples, Mono-RL, Di-RL, or a 1:1 mixture of Mono-RL and Di-RL, respectively, are used as the biosurfactant. In another comparative example, a mixture of sophorolipids of formula (X) is used as the biosurfactant. In another comparative example, a mixture of sophorolipids of formula (XII) is used as the biosurfactant. In another comparative example, a 1:1 mixture of sophorolipids of formula (X) and sophorolipids of formula (XII) is used as the biosurfactant. In yet another comparative example, a 1:1:1:1 mixture of sophorolipid derivatives of formulas (5), (6), (7), and (8) of EP 4 317 448 A1 is used as the biosurfactant. In another comparative example, a 1:1 mixture of sophorolipid derivatives of formulas (IV), (V) of EP 3 034 613 A1 is used as the biosurfactant.**The proportions represent the respective amount of each component; dilutions in the products used are taken into account in the quantity used. ***SLES 1EO is added as an anionic surfactant. The inventive protocol for producing a dispersion that can then be used as shampoo or, preferably, as dishwashing liquid, and even more preferably as hand dishwashing liquid, is as follows: 1. A mixture of GL and an anionic surfactant is placed on the surface. 2. Water is added while stirring. 3. Carbopol 980 is added while stirring for at least 30 minutes. 4. A premixed mixture of Jaguar C14S and perfume is added and stirred for at least 20 minutes. 5. Silicone oil is added and stirred for at least 10 minutes. 6. CAPB is added slowly and stirred for at least 10 minutes. 7. DMDM ​​hydatoin is added. 8. The pH is adjusted to 5.5–6.5 with NaOH. 9. If necessary, NaCl is added and stirred for at least 10 minutes. 10. The encapsulated active ingredient is added and stirred for at least 10 minutes. For comparison purposes, the protocol is repeated, except that in step 1, instead of GL, the same amount of Mono-RL, Di-RL or a 1:1 mixture of Mono-RL and Di-RL or the sophorolipids or sophorolipid derivatives described above are added. The compositions in the Falcon vessel are then centrifuged in a small centrifuge CD-0412-50 (Phoenix Instrument) at 3000 min-1. Experiment series II: Experiment series I is repeated, except that LAS is added as the anionic surfactant instead of SLES 1EO. Experiment series III: Experiment series I is repeated, except that a 50 : 50 (wt%) mixture of LAS and SLES 1EO is added as the anionic surfactant. When comparing mixtures containing GL as a biosurfactant with those containing Mono-RL, Di-RL, or a 1:1 mixture of Mono-RL and Di-RL as the biosurfactant, and whose components are otherwise identical, it was found that in the GL-containing mixtures, the active ingredient capsules only visibly separated after longer centrifugation than in the directly comparable RL-containing mixtures. This advantage was also confirmed in comparison tests with sophorolipids or sophorolipid derivatives. It is also noted that this effect is only achieved when the mixture of surfactant (here anionic surfactant) and GL is presented and the active ingredient capsules (possibly after adding the other components) are added to this mixture. It is also confirmed that the GL in the dispersions according to the invention exhibit improved foaming properties. Furthermore, they also ensure a softer feel in the dispersions according to the invention. Further dispersions according to and not according to the invention D: 1) Another dispersion D according to the invention is obtained by reproducing the laundry formulation shown on page 19 of WO 2014 / 118095 A1 (“Aiundry formulation”), except that the same amount (14 wt%) of glucolipid is used instead of “Rhamnolipid JBR425 ex Jeneil”. 2) Another dispersion D according to the invention is obtained by reproducing the personal wash composition shown on page 20 of WO 2014 / 118095 A1, except that the same amount (6 wt%) of glucolipid is used instead of “Biosurfactant (JBR425)”. The resulting formulation also exhibits improved foaming behavior compared to the corresponding formulation containing "Biosurfactant (JBR425)" when comparing both formulations in the foam test on page 21, lines 6 to 24 of WO 2014 / 118095 A1. An improvement is also observed with glucolipid compared to both monoRL and diRL. QUOTES INCLUDED IN THE DESCRIPTION This list of documents cited by the applicant was automatically generated and is included solely for the reader's convenience. The list is not part of the German patent or utility model application. The DPMA accepts no liability for any errors or omissions. Cited patent literature WO 2019 / 154970 A1 [0004, 0017, 0233]WO 2014 / 118095 A1 [0005, 0079, 0253]WO 2011 / 120776 A1

[0006] WO 2014 / 173659 A1 [0007, 0008, 0079, 0102, 0203]EP 0 499 434 A1

[0017] DE 196 48 439 A1

[0017] DE 196 00 743 A1

[0017] EP 3 061 442 A2

[0017] WO 03 / 006146 A1

[0017] US 2008 / 0213194 A1

[0017] JP H01-304034 A1

[0017] CN 1337439 A

[0017] WO 03 / 002700 A1

[0017] US 4,305,961 A

[0017] US 7,556,654 B1

[0017] EP 1 411 111 B1

[0064] EP 1 411 111 A1

[0064] EP 4 317 448 A1 [0065, 0245]EP 3 034 613 A1 [0065, 0245]JP S58-217598 A

[0075] WO 90 / 13533 A1

[0075] US 3,234,258 A

[0083] US 5,075,041 A

[0083] US 3,516,941 A

[0117] US 2,800,457 A

[0117] US 4,145,184 A

[0117] US 5,112,688 A

[0117] US 4,406,816 A

[0119] GB 2,062,570 A

[0119] GB 2,006,709 A

[0119] US 5,578,563 A

[0167] WO 2016 / 146497 A1

[0213] WO 2012 / 010405 A1

[0214] EP 3 061 442 A1 [0235, 0236] Zitierte Nicht-Patentliteratur F. Khorshahi, S. Lin, A. Jensen, D. Kwoh, Polymer Bulletin 1992, 28, 451 - 458

[0153] George A. Burdock, „Fenaroli's Handbook of Flavor Ingredients“, 6. Auflage, 2009, CRC Press

[0156] Morris Boris Jacobs, „Synthetic Food Adjuncts“, 2013, Literary Licensing LLC

[0156] Steffen Arctander, „Perfume and Flavor Chemicals“, 1969, Montclair, N. J. (USA

[0156] Kopfnoten“ werden von W.A. Poucher, Journal of the Society of Cosmetic Chemists 1955, 6, 80 - 94

[0159]

Claims

A process for producing a preferably aqueous dispersion D of active ingredient capsules W, comprising at least one active ingredient B, the process comprising the following steps: a) providing a mixture M comprising a surfactant combination, preferably consisting of i. at least one glucolipid G, ii. at least one surfactant TS other than G, b) adding the active ingredient capsules WK to M, thereby obtaining a dispersion D. Method according to claim 1, wherein the mixture M is stirred during step b). Method according to claim 1 or 2, wherein the dispersion D is stirred after step b). Method according to any one of claims 1 to 3, wherein the mass of all glucolipids G in the mixture M provided in step a), based on the total weight of all glucolipids G and all surfactants Ts in the mixture M provided in step a), is in the range of 10 wt.% to 95 wt.%, in particular in the range of 25 wt.% to 75 wt.%. Method according to any one of claims 1 to 4, wherein the active ingredient capsules W have no diameter of ≥ 3 µm. Method according to any one of claims 1 to 5, wherein the active ingredient capsules WK have a shell S enclosing a core K, wherein at least one active ingredient B is located in the core K. Method according to any one of claims 1 to 6, wherein the active ingredient capsules WK, in particular the shell S of the active ingredient capsules WK, comprise urea-formaldehyde and / or melamine-formaldehyde. Method according to any one of claims 1 to 7, wherein the active ingredient capsules WK are such that release the at least one active ingredient B by applying pressure and / or shear forces, in particular friction, pressure and / or shear stress, to the active ingredient capsules WK. Method according to any one of claims 1 to 8, wherein the active ingredient capsules WK are such that release the at least one active ingredient B by B diffusing out of the active ingredient capsule WK. Method according to any one of claims 1 to 10, wherein the active ingredient B is selected from the group consisting of skin-conditioning active ingredient, olfactory active ingredient, volatile active ingredient. A method according to any one of claims 1 to 10, wherein the active ingredient B is selected from the group consisting of: perfumes, insect repellents, essential oils, menthol-containing fragrances and aromatherapy active ingredients, humectants and / or emollients for skin and / or hair, comprising mineral oil, petrolatum, silicone oil, comprising dimethyl polysiloxane, lauryl and myristyl lactate, anti-dandruff agents, which are in particular selected from the group consisting of zinc salts, in particular zinc pyrithione, zinc sulfate and hydrates thereof;-Piroctone olamine, selenium sulfide, azole antimicrobial agents, in particular climbazole, -silicones, in particular selected from the group consisting of polyalkylsiloxanes, polyarylsiloxanes, polyalkylarylsiloxanes, polyethersiloxane copolymer, aminosilicones, silicone rubbers, cross-linked silicone elastomers, -cationic polymers, in particular a cationic guar gum derivative, preferably guar hydroxypropyltrimonium chloride.; Method according to any one of claims 1 to 11, wherein in step a) the mixture M is provided in a container C and in step b) the active ingredient capsules WKzu M are added to the container C. Dispersion D obtained in a process according to any one of claims 1 to 12. Method for treating, preferably for washing and / or rinsing, a substrate S using a washing solution, comprising generating a washing solution by mixing the dispersion D according to claim 13 with water, and contacting the washing solution with the substrate S. Method according to claim 14, wherein the substrate S is selected from an object and a part of the human or animal body, wherein S is preferably an object. Method according to claim 15, wherein the object is selected from fabrics, nonwovens, objects with hard surfaces, preferably tableware. Use of the dispersion D according to claim 13 as a shampoo, textile detergent or as a dishwashing detergent, in particular as a hand dishwashing detergent.

Images